Open AccessDouble‐edged sword of mesenchymal stem cells: Cancer‐promoting versus therapeutic potential
Author(s) -
Lee HwaYong,
Hong InSun
Publication year - 2017
Publication title -
cancer science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 1347-9032
DOI - 10.1111/cas.13334
Subject(s) - mesenchymal stem cell , cancer research , pathogenesis , immune system , adipose tissue , cancer , stem cell , immunology , bone marrow , biology , medicine , pathology , microbiology and biotechnology
Mesenchymal stem cells ( MSCs ) derived from adipose tissue, bone marrow, cord blood, and other tissues, have recently attracted much attention as potential therapeutic agents in various diseases because of their trans‐differentiation capacity. However, recent studies have suggested that MSCs also appear to contribute to tumor pathogenesis by supporting tumor microenvironments, increasing tumor growth, and eliciting antitumor immune responses. Although some studies suggest that MSCs have inhibitory effects on tumor development, they are overwhelmed by a number of studies showing that MSCs exert stimulatory effects on tumor pathogenesis. In the present review, we summarize a number of findings to provide current information about the therapeutic potential of MSCs in various diseases. We then discuss the potential roles of MSCs in tumor progression.